JP2023538130A5 - - Google Patents
Info
- Publication number
- JP2023538130A5 JP2023538130A5 JP2023512700A JP2023512700A JP2023538130A5 JP 2023538130 A5 JP2023538130 A5 JP 2023538130A5 JP 2023512700 A JP2023512700 A JP 2023512700A JP 2023512700 A JP2023512700 A JP 2023512700A JP 2023538130 A5 JP2023538130 A5 JP 2023538130A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor
- composition
- manipulated
- vector
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063068890P | 2020-08-21 | 2020-08-21 | |
| US63/068,890 | 2020-08-21 | ||
| PCT/US2021/046915 WO2022040535A2 (en) | 2020-08-21 | 2021-08-20 | Compositions and methods for neurological diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538130A JP2023538130A (ja) | 2023-09-06 |
| JP2023538130A5 true JP2023538130A5 (https=) | 2024-08-28 |
Family
ID=80350587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512700A Pending JP2023538130A (ja) | 2020-08-21 | 2021-08-20 | 神経疾患のための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240317834A1 (https=) |
| EP (1) | EP4200020A4 (https=) |
| JP (1) | JP2023538130A (https=) |
| KR (1) | KR20230061409A (https=) |
| CN (1) | CN116802201A (https=) |
| AU (1) | AU2021329529A1 (https=) |
| BR (1) | BR112023003167A2 (https=) |
| CA (1) | CA3192604A1 (https=) |
| IL (1) | IL300816A (https=) |
| MX (1) | MX2023002161A (https=) |
| WO (1) | WO2022040535A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117487904B (zh) * | 2023-12-28 | 2024-05-31 | 湖南家辉生物技术有限公司 | Gabrb3基因突变体、突变体蛋白、试剂、试剂盒及应用 |
| CN119331917B (zh) * | 2024-10-28 | 2025-10-17 | 北京爱思益普生物科技股份有限公司 | 能够表达GlyR α1/β型GlyR的细胞株及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL304040B2 (en) * | 2016-07-07 | 2024-09-01 | Hughes Howard Med Inst | Modified ligand-gated ion channels and methods of use |
| US10538571B2 (en) * | 2017-11-27 | 2020-01-21 | Coda Biotherapeutics, Inc. | Compositions and methods for neurological diseases |
| AU2020334147A1 (en) * | 2019-08-21 | 2022-03-31 | Trames Bio, Inc. | Compositions and methods for neurological diseases |
-
2021
- 2021-08-20 IL IL300816A patent/IL300816A/en unknown
- 2021-08-20 WO PCT/US2021/046915 patent/WO2022040535A2/en not_active Ceased
- 2021-08-20 EP EP21859205.3A patent/EP4200020A4/en active Pending
- 2021-08-20 CA CA3192604A patent/CA3192604A1/en active Pending
- 2021-08-20 US US18/022,358 patent/US20240317834A1/en active Pending
- 2021-08-20 JP JP2023512700A patent/JP2023538130A/ja active Pending
- 2021-08-20 KR KR1020237009591A patent/KR20230061409A/ko active Pending
- 2021-08-20 CN CN202180070391.2A patent/CN116802201A/zh active Pending
- 2021-08-20 MX MX2023002161A patent/MX2023002161A/es unknown
- 2021-08-20 AU AU2021329529A patent/AU2021329529A1/en active Pending
- 2021-08-20 BR BR112023003167A patent/BR112023003167A2/pt unknown